C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2006
11/02/2006	US20060247191 Chimeric cytoplasmic signalling molecules
11/02/2006	US20060247176 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression
11/02/2006	US20060247164 Meltrins
11/02/2006	US20060246587 Methods for transfecting T cells
11/02/2006	US20060246568 Cytidine deaminase
11/02/2006	US20060246550 Construction of antibody using mrl/lpr mouse
11/02/2006	US20060246549 Peptide acceptor ligation methods
11/02/2006	US20060246548 CE7-specific redirected immune cells
11/02/2006	US20060246547 Nematode-extracted serine protease inhibitors and anticoagulant proteins
11/02/2006	US20060246546 Manufacture of biologic cellular products
11/02/2006	US20060246545 Gene inactivated mutants with altered protein production
11/02/2006	US20060246544 Manufacturing process for the production of peptides grown in insect cell lines
11/02/2006	US20060246543 Slim compositions and methods of use thereof
11/02/2006	US20060246542 System for antibody expression and assembly
11/02/2006	US20060246541 eukaryotic proteins that require formation of disulfide bridges for biological activity; comprising a thioredoxin located N-terminal to the domain
11/02/2006	US20060246540 Monoclonal, humanized, fragmented or labeled antibodies; extracellular proteins; expression vectors; host cells
11/02/2006	US20060246539 Protein production method utilizing yebF
11/02/2006	US20060246538 Capable of sodium-independently transporting branched amino acids
11/02/2006	US20060246537 Multi-step process for the manufacture of therapeutic protein
11/02/2006	US20060246521 Serum tumor marker in rodent prostate cancer models
11/02/2006	US20060246519 For use in the capture and/or purification of biotinylated proteins
11/02/2006	US20060246509 Unnatural reactive amino acid genetic code additions
11/02/2006	US20060246506 Non-competitive immunoassay for small analytes
11/02/2006	US20060246502 Screening for a material that promotes or inhibits binding between a rabconnectin-3-binding protein having a specific amino acid sequence and rabconnectin-3 and therefore would be useful for regulating Ca2+-dependent exocytosis
11/02/2006	US20060246498 HNRPLL polypeptides, polynucleotides encoding same and compositions and methods of using same
11/02/2006	US20060246491 Micro-RNA's that regulate muscle cells
11/02/2006	US20060246486 Human signal peptide-containing proteins
11/02/2006	US20060246483 Identifying and characterizing novel human secreted proteins and their genes ; promotes vascularization; screening methods
11/02/2006	US20060246477 Method for generating variable domain sequences of heavy chain antibodies
11/02/2006	US20060246471 Compositions and methods for screening pro-apoptotic compounds
11/02/2006	US20060246468 enzyme inhibitors; useful in the production of carbohydrate chains within glycoproteins/glycolipids; detecting, or inhibiting the production of, the alpha -1,3-fucosyltransferase which involves the use of cDNA coding the enzyme
11/02/2006	US20060246465 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/02/2006	US20060246461 Nucleotide sequence coding membrane protein; diagnosis of tumor, cancer
11/02/2006	US20060246456 Fucose transporter
11/02/2006	US20060246452 Method for identifying nucleic acid molecules associated with angiogenesis
11/02/2006	US20060246450 Ligational encoding of small molecules
11/02/2006	US20060246442 Using zinc transporter protein-8 to identify modulators for treatment and diagnosis of diabetic disorders
11/02/2006	US20060246125 Proteoliposome for use as gene transfer tool in treatment and diagnosis of cardiomyopathy, type II diabetes, Alzheimer's, Parkinson's diseases; gene therapy
11/02/2006	US20060246095 Multiepitope polypeptides for cancer immunotherapy
11/02/2006	US20060246082 Therapeutic peptides and method
11/02/2006	US20060246077 Use of antibodies against the MUC18 antigen
11/02/2006	US20060246069 Inflammation and immunopathy caused by human anti-human Monocyte chemoattractant protein-1
11/02/2006	US20060246068 Polypeptides having a triggering NK activity and biological applications
11/02/2006	US20060246067 Immunomodulatory constructs and their uses
11/02/2006	US20060246065 Fail molecules and uses thereof
11/02/2006	US20060246064 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab
11/02/2006	US20060246062 Anti-ccr4 antibodies and methods of use therefor
11/02/2006	US20060246061 Method for generating monoclonal antibodies
11/02/2006	US20060246059 therapeutic protein comprising a tenth domain of fibronectin type III; protein scaffold; antibody design; scaffold derived from a fibronectin type III (Fn3) or Fn3-like domain, function like natural or engineered antibodies; antibody mimics designed for optimal folding, stability, and solubility
11/02/2006	US20060246051 Male reproductive disorders including proliferative disorders of testes
11/02/2006	US20060246049 Compositions and methods for enzymatic detachment of bacterial and fungal biofilms
11/02/2006	US20060246048 Elongation of fatty acids(ELF) polypeptides and carrier mixtures administered for prophylaxis of vision defects
11/02/2006	US20060246047 Peptide wirh apoptosis-inhibiting activity
11/02/2006	US20060246046 Modified tridegins, production and use thereof as transglutaminase inihibitors
11/02/2006	US20060246039 Growth differentiation factor-7
11/02/2006	US20060246024 Method for stimulating hair follicle cell proliferation
11/02/2006	US20060246004 Antibody variants and uses thereof
11/02/2006	EP1717587A1 Method and kit for identifying the function of gene product and identifying binding substance
11/02/2006	EP1717316A1 Interferon-like protein ZCYTO21
11/02/2006	EP1717315A2 Osteoprotegerin binding proteins and receptors
11/02/2006	EP1717314A1 Receptor for modified low-density lipoprotein
11/02/2006	EP1717251A2 Methods of therapy for B-cell malignancies using human anti-CD40 antibodies
11/02/2006	EP1717250A1 Monoclonal antibody and use thereof
11/02/2006	EP1717244A1 Akt activity specifically inhibiting polypeptide
11/02/2006	EP1716244A2 H. pylori fucosyltransferases
11/02/2006	EP1716232A2 Acid alpha-glucosidase and fragments thereof
11/02/2006	EP1716225A2 Method for the production of recombined proteins in eukaryontic host cells
11/02/2006	EP1716170A2 Hyphal growth in fungi
11/02/2006	EP1417301B1 Carbohydrates and polyols for dissolving protein crystals
11/02/2006	EP1412758B1 Protein arrays, methods for their preparation and methods for the detection of intermolecular interactions
11/02/2006	EP1208192B1 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers
11/02/2006	EP1147137B9 Methods for generating phosphorylation site-specific immunological reagents
11/02/2006	EP1107768B1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE
11/02/2006	EP1009834B1 Regulation of protein secretion
11/02/2006	EP1006785B1 Antimicrobial proteins
11/02/2006	EP1003874B1 Neisseria lactoferrin binding protein
11/02/2006	CA2607455A1 Antibodies with immune effector activity and that internalize in endosialin-positive cells
11/02/2006	CA2607444A1 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells
11/02/2006	CA2606222A1 Reagents that bind ccx-ckr2
11/02/2006	CA2606102A1 Modulation of antibody effector function by hinge domain engineering
11/02/2006	CA2605924A1 Recombinant flavivirus vaccines
11/02/2006	CA2605149A1 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein
11/02/2006	CA2605140A1 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein
11/02/2006	CA2604786A1 Single-chain antibody with cleavable linker
11/01/2006	CN1856569A Animal product free system and process for purifying a botulinum toxin
11/01/2006	CN1856508A Human monoclonal antibody fab fragments directed against HCV E2 glycoprotein and endowed with in vitro neutralizing activity
11/01/2006	CN1856324A Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds
11/01/2006	CN1854306A Production of recombinant human serum albumin HSA by fermentation
11/01/2006	CN1854305A Production of brain-tonifying nutrient oyster peptide
11/01/2006	CN1854299A Production of recombinant insulinum primary C peptide
11/01/2006	CN1854296A Production of recombinant human interferon beta
11/01/2006	CN1854295A Production of specific micro-antibody for oarium cancer
11/01/2006	CN1854294A Escherichia expression system of secretory expression recombinant human epidermal growth factor
11/01/2006	CN1854157A Antibodies to insulin-like growth factor i receptor
11/01/2006	CN1854150A Factor VIII separation
11/01/2006	CN1282748C Method for preparing leukocyte interferon of pig
10/2006
10/31/2006	US7129390 A vector containing a coding sequence and a promoter to express such sequence in an avian oviduct, and the sequence is either recombinant transgenic poultry derived interferon-alpha 2b or erythropoietin coding sequence
10/31/2006	US7129343 Enhancing transcription via TATA Box census element as core of promoter
10/31/2006	US7129342 Infectious cDNA clone of GB virus B and uses thereof
10/31/2006	US7129337 Hepatitis C virus (HCV) polynucleic acid of given nucleotide sequence unique to at least one of the new HCV subtypes 7,9,10 OR 11, OR TO SUBTYPES 1D, 1E, 1F, 1G, 2E, 2F, 2G, 2H, 2I, 2K, 2L,3G,4K OR 4M; producing recombinant polypeptide

1 ... 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 ... 1125